Richardson, A
The GLP-1 Plate : The Science of Activating Endogenous GLP-1 Through Whole Food Chemistry, Bone Broth, and Strategic Fasting - Kindle edition by Zimmerman, Veronica D
For individuals with heart disease and type 2 diabetes, semaglutide can lower the risk of serious cardiovascular issues
(2020)-who published pioneer studies on the pharmacological relevance of the GSH precursor N-acetylcysteine (NAC) in the 80s and 90sstresses the need for thiols supplementation for both the prevention and treatment of COVID-19
Semaglutide was approved in 2022 for use alongside lifestyle changes in pediatric patients aged 12 or older with an initial BMI equal to or greater than the 95th percentile for their age and sex
Combining the results from 37 different studies involving over 2,000 people, L-carnitine supplementation led to an average weight loss of about 1.2 kg (roughly 2.7 pounds), a small drop in BMI (0.24 kg/m), and a reduction in fat mass by about 2 kg